In his recent article, Dr. Hassan Kafri sheds light on the rising popularity of compounded GLP-1 medications as an alternative to FDA-approved treatments like semaglutide. Due to the current shortage of these highly effective medications, compounded versions are becoming more common. However, Dr. Kafri warns that not all compounded medications are safe, and those sourced from unregulated pharmacies can be harmful, posing risks to both health and treatment outcomes.
Dr. Kafri emphasizes that medications alone are not a magic fix for obesity. Sustainable weight loss requires a comprehensive approach that includes healthy lifestyle changes, such as a balanced diet and regular physical activity. Relying solely on medication without these habits increases the risk of regaining lost weight once treatment is stopped.
One patient’s story illustrates this point clearly: after losing 25 pounds on a compounded GLP-1 medication, they eventually had to stop due to the high cost. Unfortunately, they regained all of the lost weight and more, highlighting the importance of long-term, accessible treatment options and lifestyle support.
Dr. Kafri’s advice serves as a reminder that safe, sustainable weight management should focus on both regulated treatment options and meaningful lifestyle changes. His article encourages patients to work closely with healthcare providers to ensure the best approach to achieving and maintaining their health goals.
Read the full article here
Follow Our Journey
Stay updated on the latest insights and developments by following us on social media:
LinkedIn | Twitter/X | Instagram
